Episode Details
Back to Episodes
Allopurinol Fixes the Numbers and Little Else
Description
The Filtrate:
Joel Topf
Swapnil Hiremath
Samira Farouk
And special guests:
Katalin Susztak, Professor of Medicine Perlman School of Medicine, University of Pennsylvania. @KSusztak
Show Notes:
CKD-FIX: Effects of Allopurinol on the Progression of Chronic Kidney Disease
PERL: Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
Coverage at NephJC: Effects of Allopurinol on the Progression of Chronic Kidney Disease
Richard Johnson’s theory in pay-walled Nature Reviews Nephrology: Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome
Richard Johnson’s theory in open access Nehrology Dialysis and Transplantation: Uric acid and chronic kidney disease: which is chasing which?
PERL: Preventing early renal loss
Iohexol, good for measuring GFR as well as causing contrast associated nephropathy?
Uric acid versus urate: The Crystallization of Monosodium Urate
WHO list of essential medications
Fixing the numbers, specifically phosphorous
Cost of allopurinol: $7/month but it is only $9 for 3 months
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Tipping point analysis - multiple imputation for stress test under missing not at random (MNAR) or a YouTube video if that’s your speed (sorry, I couldn’t find a TikTok on imputation stress tests).
Mendelian randomization study of urate and CKD by Ron Do and team
Fake systematic review by Johnson’s group showing Urate lowering prevented CKD
Listen Now
Love PodBriefly?
If you like Podbriefly.com, please consider donating to support the ongoing development.
Support Us